ARBAZ AHMAD: Open Payments
NPI 1861171670 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 34 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $591 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $410 |
| Lilly USA, LLC | 6 | $114 |
| ABBVIE INC. | 4 | $79 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Cranial Technologies, Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Wegovy, Rybelsus, Ozempic, ZEPBOUND, MOUNJARO, UBRELVY, QULIPTA, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
